Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)Retained EarningsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pharming (PHAR) Current Leases (2019 - 2025)

Historic Current Leases for Pharming (PHAR) over the last 7 years, with Q3 2025 value amounting to $28.1 million.

  • Pharming's Current Leases rose 110.14% to $28.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.1 million, marking a year-over-year increase of 110.14%. This contributed to the annual value of $27.0 million for FY2024, which is 64579.65% up from last year.
  • Per Pharming's latest filing, its Current Leases stood at $28.1 million for Q3 2025, which was up 110.14% from $27.5 million recorded in Q2 2025.
  • In the past 5 years, Pharming's Current Leases ranged from a high of $31.1 million in Q1 2023 and a low of $7744.0 during Q1 2021
  • Moreover, its 5-year median value for Current Leases was $26.5 million (2025), whereas its average is $19.2 million.
  • Data for Pharming's Current Leases shows a peak YoY increase of 23104669.42% (in 2022) and a maximum YoY decrease of 9992.12% (in 2022) over the last 5 years.
  • Quarter analysis of 5 years shows Pharming's Current Leases stood at $18628.4 in 2021, then surged by 18500.61% to $3.5 million in 2022, then increased by 4.36% to $3.6 million in 2023, then skyrocketed by 645.8% to $27.0 million in 2024, then grew by 4.16% to $28.1 million in 2025.
  • Its last three reported values are $28.1 million in Q3 2025, $27.5 million for Q2 2025, and $26.5 million during Q1 2025.